Cargando…
Gut microbiota deficiency ameliorates multiple myeloma and myeloma-related bone disease by Th17 cells in mice models
Purpose: Multiple myeloma, the second most common hematological tumor, is currently incurable. Multiple myeloma-related bone disease is a characteristic clinical symptom that seriously affects the survival and prognosis of patients. In recent years, gut microbiota has been shown to play an important...
Autores principales: | Liu, Jia, Xie, Fang, Yi, Zhi-gang, Ma, Tao, Tie, Wen-ting, Li, Yan-hong, Bai, Jun, Zhang, Lian-sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622987/ https://www.ncbi.nlm.nih.gov/pubmed/37928417 http://dx.doi.org/10.7150/jca.88799 |
Ejemplares similares
-
Bone marrow IRF4 level in multiple myeloma: an indicator of peripheral blood Th17 and disease
por: Bai, Hua, et al.
Publicado: (2017) -
The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma
por: Braga, Walter M. T., et al.
Publicado: (2012) -
P850: THE EFFECT OF UROLITHIN PRODUCTION BY GUT MICROBIOTA IN MULTIPLE MYELOMA
por: Rodríguez-García, Alba, et al.
Publicado: (2023) -
The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple Myeloma
por: Brevi, Arianna, et al.
Publicado: (2022) -
The Interaction between Gut Microbiota and Host Amino Acids Metabolism in Multiple Myeloma
por: Yang, Qin, et al.
Publicado: (2023)